Category: Funding

Xealth Platform - Series B Funding - Digital Health News

Xealth Raises $24 Million Series B Funding to Accelerate Digital Health

Xealth, a leading digital health solutions enabler, has closed its Series B funding with $24 million, advancing digital connections between clinicians and their patients, driving better outcomes. The Xealth digital health platform is currently available to more than 100,000 physicians, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Xealth’s Series B funding round will fuel the growth of the company’s team, approximately doubling its size. It will also support product innovation, including further enhancing its intelligence engine to help better health systems determine which tools are working best with which patients, further enabling the scale of Xealth’s deployment across the US.

Transforming the Telehealth Experience for Patients and Clinicians | Amwell Files IPO…Google Cloud to Invest $100 Million

Amwell has filed to go public under the New York Stock Exchange symbol AMWL. Google Cloud’s $100 million investment will be a concurrent private placement at the IPO price. The company didn’t indicate a proposed size for the offering, nor did it give an anticipated price range, but it provided a placeholder amount of $100 million to calculate its registration fee. Morgan Stanley, Goldman Sachs & Co., LLC, Piper Sandler, UBS Investment Bank, Credit Suisse and Cowen Berenberg are listed as underwriters for the IPO.

Caption Health Raises $53 Million to Expand and Commercialize its FDA-Cleared, AI-Guided Ultrasound Technology

Caption Health, a leading medical artificial intelligence (AI) company, concluded its Series B funding round with $53 million to expand and commercialize its FDA-cleared, AI-guided ultrasound technology that improves patient access to high-quality and essential care. The strategy is to use this investment to scale commercial operations, continue to develop its AI technology platform, and form new partnerships. New clinical capabilities are planned with increased clinical adoption of the Caption AI platform.

Anthem’s PBM, IngenioRx, Acquires Pharmacy Startup ZipDrug

IngenioRx, Inc., a wholly owned subsidiary of Anthem, Inc., announced its acquisition of ZipDrug an innovative pharmacy management company focused on improving the quality of pharmacy care. Now part of IngenioRx, ZipDrug seamlessly connects patients to the highest quality and lowest cost local pharmacies that deliver directly to patients at home.